416 related articles for article (PubMed ID: 22189029)
1. Dosimetric implications of residual seminal vesicle motion in fiducial-guided intensity-modulated radiotherapy for prostate cancer.
Stenmark MH; Vineberg K; Ten Haken RK; Hamstra DA; Feng M
Med Dosim; 2012; 37(3):240-4. PubMed ID: 22189029
[TBL] [Abstract][Full Text] [Related]
2. A novel approach for evaluation of prostate deformation and associated dosimetric implications in IGRT of the prostate.
Mayyas E; Kim J; Kumar S; Liu C; Wen N; Movsas B; Elshaikh MA; Chetty IJ
Med Phys; 2014 Sep; 41(9):091709. PubMed ID: 25186384
[TBL] [Abstract][Full Text] [Related]
3. Margin evaluation in the presence of deformation, rotation, and translation in prostate and entire seminal vesicle irradiation with daily marker-based setup corrections.
Mutanga TF; de Boer HC; van der Wielen GJ; Hoogeman MS; Incrocci L; Heijmen BJ
Int J Radiat Oncol Biol Phys; 2011 Nov; 81(4):1160-7. PubMed ID: 21035957
[TBL] [Abstract][Full Text] [Related]
4. Prostate and seminal vesicle volume based consideration of prostate cancer patients for treatment with 3D-conformal or intensity-modulated radiation therapy.
Reddy NM; Nori D; Chang H; Lange CS; Ravi A
Med Phys; 2010 Jul; 37(7):3791-801. PubMed ID: 20831087
[TBL] [Abstract][Full Text] [Related]
5. Residual seminal vesicle displacement in marker-based image-guided radiotherapy for prostate cancer and the impact on margin design.
Smitsmans MH; de Bois J; Sonke JJ; Catton CN; Jaffray DA; Lebesque JV; van Herk M
Int J Radiat Oncol Biol Phys; 2011 Jun; 80(2):590-6. PubMed ID: 20888710
[TBL] [Abstract][Full Text] [Related]
6. Online image-guided intensity-modulated radiotherapy for prostate cancer: How much improvement can we expect? A theoretical assessment of clinical benefits and potential dose escalation by improving precision and accuracy of radiation delivery.
Ghilezan M; Yan D; Liang J; Jaffray D; Wong J; Martinez A
Int J Radiat Oncol Biol Phys; 2004 Dec; 60(5):1602-10. PubMed ID: 15590192
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of online/offline image guidance/adaptation approaches for prostate cancer radiation therapy.
Qin A; Sun Y; Liang J; Yan D
Int J Radiat Oncol Biol Phys; 2015 Apr; 91(5):1026-33. PubMed ID: 25832693
[TBL] [Abstract][Full Text] [Related]
8. Image-guided intensity-modulated radiotherapy of prostate cancer: Analysis of interfractional errors and acute toxicity.
Rudat V; Nour A; Hammoud M; Alaradi A; Mohammed A
Strahlenther Onkol; 2016 Feb; 192(2):109-17. PubMed ID: 26545764
[TBL] [Abstract][Full Text] [Related]
9. The role of seminal vesicle motion in target margin assessment for online image-guided radiotherapy for prostate cancer.
Liang J; Wu Q; Yan D
Int J Radiat Oncol Biol Phys; 2009 Mar; 73(3):935-43. PubMed ID: 19111401
[TBL] [Abstract][Full Text] [Related]
10. Relationship between pelvic organ-at-risk dose and clinical target volume in postprostatectomy patients receiving intensity-modulated radiotherapy.
Stanic S; Mathai M; Cui J; Purdy JA; Valicenti RK
Int J Radiat Oncol Biol Phys; 2012 Apr; 82(5):1897-902. PubMed ID: 21536391
[TBL] [Abstract][Full Text] [Related]
11. Quantification of prostate and seminal vesicle interfraction variation during IMRT.
Frank SJ; Dong L; Kudchadker RJ; De Crevoisier R; Lee AK; Cheung R; Choi S; O'Daniel J; Tucker SL; Wang H; Kuban DA
Int J Radiat Oncol Biol Phys; 2008 Jul; 71(3):813-20. PubMed ID: 18207664
[TBL] [Abstract][Full Text] [Related]
12. Dosimetric comparison of four target alignment methods for prostate cancer radiotherapy.
O'Daniel JC; Dong L; Zhang L; de Crevoisier R; Wang H; Lee AK; Cheung R; Tucker SL; Kudchadker RJ; Bonnen MD; Cox JD; Mohan R; Kuban DA
Int J Radiat Oncol Biol Phys; 2006 Nov; 66(3):883-91. PubMed ID: 17011461
[TBL] [Abstract][Full Text] [Related]
13. Plan Selection in Proton Therapy of Locally Advanced Prostate Cancer with Simultaneous Treatment of Multiple Targets.
Pilskog S; Abal B; Øvrelid KS; Engeseth GM; Ytre-Hauge KS; Hysing LB
Int J Radiat Oncol Biol Phys; 2020 Mar; 106(3):630-638. PubMed ID: 31759076
[TBL] [Abstract][Full Text] [Related]
14. Quantitative evaluation of the benefit of fiducial image-guidance for prostate cancer intensity modulated radiation therapy using daily dose volume histogram analysis.
Kasaova L; Sirak I; Jansa J; Paluska P; Petera J
Technol Cancer Res Treat; 2014 Feb; 13(1):47-55. PubMed ID: 23819493
[TBL] [Abstract][Full Text] [Related]
15. PTV margin definition in hypofractionated IGRT of localized prostate cancer using cone beam CT and orthogonal image pairs with fiducial markers.
Oehler C; Lang S; Dimmerling P; Bolesch C; Kloeck S; Tini A; Glanzmann C; Najafi Y; Studer G; Zwahlen DR
Radiat Oncol; 2014 Nov; 9():229. PubMed ID: 25384898
[TBL] [Abstract][Full Text] [Related]
16. Strategies for online organ motion correction for intensity-modulated radiotherapy of prostate cancer: prostate, rectum, and bladder dose effects.
Rijkhorst EJ; Lakeman A; Nijkamp J; de Bois J; van Herk M; Lebesque JV; Sonke JJ
Int J Radiat Oncol Biol Phys; 2009 Nov; 75(4):1254-60. PubMed ID: 19857789
[TBL] [Abstract][Full Text] [Related]
17. Dosimetric adaptive IMRT driven by fiducial points.
Crijns W; Van Herck H; Defraene G; Van den Bergh L; Slagmolen P; Haustermans K; Maes F; Van den Heuvel F
Med Phys; 2014 Jun; 41(6):061716. PubMed ID: 24877811
[TBL] [Abstract][Full Text] [Related]
18. The dosimetric impact of daily setup error on target volumes and surrounding normal tissue in the treatment of prostate cancer with intensity-modulated radiation therapy.
Algan O; Jamgade A; Ali I; Christie A; Thompson JS; Thompson D; Ahmad S; Herman T
Med Dosim; 2012; 37(4):406-11. PubMed ID: 22534138
[TBL] [Abstract][Full Text] [Related]
19. Deformation of prostate and seminal vesicles relative to intraprostatic fiducial markers.
van der Wielen GJ; Mutanga TF; Incrocci L; Kirkels WJ; Vasquez Osorio EM; Hoogeman MS; Heijmen BJ; de Boer HC
Int J Radiat Oncol Biol Phys; 2008 Dec; 72(5):1604-1611.e3. PubMed ID: 19028284
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of dosimetric margins in prostate IMRT treatment plans.
Gordon JJ; Siebers JV
Med Phys; 2008 Feb; 35(2):569-75. PubMed ID: 18383678
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
